These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30520738)

  • 1. Left Atrial Appendage Occlusion in the Management of Stroke in Patients With Atrial Fibrillation.
    Ojo A; Yandrapalli S; Veseli G; Karim M; Aronow WS; Sharma M; Frishman WH; Naidu SS; Jacobson JT; Iwai S
    Cardiol Rev; 2020; 28(1):42-51. PubMed ID: 30520738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy".
    Huijboom M; Maarse M; Aarnink E; van Dijk V; Swaans M; van der Heijden J; IJsselmuiden S; Folkeringa R; Blaauw Y; Elvan A; Stevenhagen J; Vlachojannis G; van der Voort P; Westra S; Chaldoupi M; Khan M; de Groot J; van der Kley F; van Mieghem N; van Dijk E; Dijkgraaf M; Tijssen J; Boersma L
    Am Heart J; 2022 Aug; 250():45-56. PubMed ID: 35537503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left atrial appendage occlusion in atrial fibrillation patients with a contraindication to oral anticoagulation: a focused review.
    Nishimura M; Sab S; Reeves RR; Hsu JC
    Europace; 2018 Sep; 20(9):1412-1419. PubMed ID: 29228158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
    Onalan O; Crystal E
    Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and advances in device-related thrombus in left atrial appendage occlusion.
    Tanaka T; Kawai K; Ellis CR; Srivastava M; Kawakami R; Konishi T; Shiraki T; Sekimoto T; Virmani R; Finn AV
    Future Cardiol; 2024; 20(7-8):343-358. PubMed ID: 38948932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of combined atrial fibrillation ablation and left atrial appendage occlusion after left atrial appendage electrical isolation.
    Kita K; Carlson S; Huntsinger M; Tun H; Sohn J; Doshi RN
    J Interv Card Electrophysiol; 2020 Jan; 57(1):43-55. PubMed ID: 31377973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence.
    Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D
    J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation.
    Mohanty S; Mohanty P; Trivedi C; Assadourian J; Mayedo AQ; MacDonald B; Della Rocca DG; Gianni C; Horton R; Al-Ahmad A; Bassiouny M; Burkhardt JD; Di Biase L; Gurol ME; Natale A
    J Am Heart Assoc; 2021 May; 10(9):e019664. PubMed ID: 33870705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery.
    Friedman DJ; Piccini JP; Wang T; Zheng J; Malaisrie SC; Holmes DR; Suri RM; Mack MJ; Badhwar V; Jacobs JP; Gaca JG; Chow SC; Peterson ED; Brennan JM
    JAMA; 2018 Jan; 319(4):365-374. PubMed ID: 29362794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAA occlusion is effective and safe in very high-risk atrial fibrillation patients with prior stroke: results from the multicentre German LAARGE registry.
    Ansari U; Brachmann J; Lewalter T; Zeymer U; Sievert H; Ledwoch J; Geist V; Hochadel M; Schneider S; Senges J; Akin I; Fastner C
    Clin Res Cardiol; 2024 Oct; 113(10):1451-1462. PubMed ID: 38294498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Appendage Occlusion: A Narrative Review.
    Alsagheir A; Koziarz A; Belley-Côté EP; Whitlock RP
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1753-1765. PubMed ID: 30857852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Labori F; Persson J; Bonander C; Jood K; Svensson M
    Eur Heart J; 2022 Mar; 43(13):1348-1356. PubMed ID: 34919652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is spontaneous echo contrast associated with device-related thrombus or embolic events after left atrial appendage occlusion? - Insights from the multicenter German LAARGE registry.
    Fastner C; Müller C; Brachmann J; Lewalter T; Akin I; Sievert H; Käunicke M; Zeymer U; Hochadel M; Schneider S; Senges J; Erkapic D; Weiß C
    J Interv Card Electrophysiol; 2024 Jan; 67(1):119-128. PubMed ID: 37261553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atrial fibrillation in severe and end stage renal disease: from oral anticoagulation therapy to percutaneous left atrial appendage occlusion].
    Merella P; Casu G; Mazzone P; Lorenzoni G; D'Angelo G; Genovesi S
    G Ital Nefrol; 2019 Feb; 36(1):. PubMed ID: 30758149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stand-Alone Left Atrial appendage occlusion for throMboembolism prevention in nonvalvular Atrial fibrillatioN DiseasE Registry (SALAMANDER): protocol for a prospective observational nationwide study.
    Kowalewski M; Wańha W; Litwinowicz R; Kołodziejczak M; Pasierski M; Januszek R; Kuźma Ł; Grygier M; Lesiak M; Kapłon-Cieślicka A; Reczuch K; Gil R; Pawłowski T; Bartuś K; Dobrzycki S; Lorusso R; Bartuś S; Deja MA; Smolka G; Wojakowski W; Suwalski P
    BMJ Open; 2022 Sep; 12(9):e063990. PubMed ID: 36130748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.